Many life-saving drugs fail for lack of funding. But there’s a solution: desperate rich people
The Audio Long Read
00:00
Crossing the Valley of Death: Funding Challenges in Drug Development
This chapter discusses the problem of abandoned drug trials and the financial hurdles that stop effective treatments from being available. It suggests allowing wealthy individuals to join clinical trials as a controversial solution to support pharmaceutical innovation.
Transcript
Play full episode
